Table 1.
Clinicopathological characteristics and LncRNA NR2F2‐AS1 expression levels in 39 non‐small cell lung cancer (NSCLC) patients
| Clinicopathological parameters | Cases | LncRNA NR2F2‐AS1 expression | |
|---|---|---|---|
| Mean ± SD | P value | ||
| Age (y) | |||
| ≤56 | 20 | 3.02 ± 0.47 | 0.177 |
| ＞56 | 19 | 3.27 ± 0.67 | |
| Gender | |||
| Male | 22 | 3.21 ± 0.57 | 0.752 |
| Female | 17 | 3.14 ± 0.65 | |
| TNM stage | |||
| I + II | 23 | 3.43 ± 0.64 | 0.029a |
| III | 16 | 2.99 ± 0.51 | |
| Lymph node metastasis | |||
| Negative | 11 | 2.74 ± 0.41 | 0.015a |
| Positive | 28 | 3.35 ± 0.59 | |
a
Indicates significant differences (P < 0.05).